CNS Pharmaceuticals, Inc. (CNSP): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-50, first reflected in a filing dated 2024-08-14; 1-for-12, first reflected in a filing dated 2025-08-14. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

632.5K
As of 2025-12-31
1.46M
As of 2026-06-30
23.86M2018-12-31: 12.69M2019-12-31: 16.45M2020-12-31: 23.86M2021-12-31: 949.1K2022-12-31: 1.62M2023-12-31: 2.5K2024-12-31: 117.8K2025-12-31: 632.5K632.5K
2018-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-31632.5K+437.0%2026-03-31, Balance as of period end
2024-12-31117.8Kn/c2026-03-31, Balance as of period end
2023-12-312.5Kn/c2025-03-31, Balance as of period end
2022-12-311.62M+70.4%2024-04-01, Balance as of period end
2021-12-31949.1K-96.0%2023-03-31, Balance as of period end
2020-12-3123.86Mn/c2022-03-03, Balance as of period end
2019-12-3116.45M+29.6%2021-02-12, Balance as of period end
2018-12-3112.69Mn/a2020-03-12, Balance as of period end